These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16533936)
1. Clopidogrel treatment prior to percutaneous coronary intervention: when enough isn't enough. Steinhubl SR; Charnigo R JAMA; 2006 Apr; 295(13):1581-2. PubMed ID: 16533936 [No Abstract] [Full Text] [Related]
2. Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban). Assali AR; Salloum J; Sdringola S; Moustapha A; Ghani M; Hale S; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR Am J Cardiol; 2001 Oct; 88(8):884-6, A6. PubMed ID: 11676953 [No Abstract] [Full Text] [Related]
3. Antiplatelet therapy for ischemic heart disease. Lange RA; Hillis LD N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308 [No Abstract] [Full Text] [Related]
4. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial. Kastrati A; Mehilli J; Neumann FJ; Dotzer F; ten Berg J; Bollwein H; Graf I; Ibrahim M; Pache J; Seyfarth M; Schühlen H; Dirschinger J; Berger PB; Schömig A; JAMA; 2006 Apr; 295(13):1531-8. PubMed ID: 16533938 [TBL] [Abstract][Full Text] [Related]
5. Contemporary use of antiplatelet therapies in percutaneous coronary interventions. Saw J; Moliterno DJ Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902 [No Abstract] [Full Text] [Related]
6. More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials. van de Werf F Eur Heart J; 1996 Mar; 17(3):325-6. PubMed ID: 8737200 [No Abstract] [Full Text] [Related]
7. Focus on adjunctive pharmacotherapy to improve outcomes of percutaneous coronary intervention. Kereiakes DJ J Invasive Cardiol; 2009 Mar; 21(3):110-3. PubMed ID: 19258641 [No Abstract] [Full Text] [Related]
8. [Impact of GP IIb/IIIa antagonists in interventional cardiology]. Scheller B; Hennen B; Böhm M; Nickenig G Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800 [No Abstract] [Full Text] [Related]
9. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379 [TBL] [Abstract][Full Text] [Related]